Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
  4. Volume 24, Issue 19
  5. Article
Volume 24, Issue 19
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Background

Germacrone, a naturally occurring active compound found in essential oils extracted from medicinal plants within the Zingiberaceae family, has garnered attention for its potential therapeutic applications. Extensive research has highlighted its multi-targeting capabilities, positioning it as a promising treatment for various chronic diseases, including cancer, cardiovascular conditions, and neurodegenerative disorders like Alzheimer's disease.

Objective

This review aims to provide a comprehensive overview of germacrone as a scaffold for developing multi-targeting drugs with therapeutic potential against a range of chronic disorders. The study delves into the molecular mechanisms that underlie the therapeutic effects of germacrone and explores its potential targets, including NF-κB, PI3K/AKT/mTOR, p53, JAK/STAT, caspase, apoptosis, and autophagy induction.

Methods

A systematic review of literature databases was conducted to gather relevant studies on germacrone and its therapeutic applications. The molecular mechanisms and potential targets of germacrone were examined to elucidate its multi-targeting capabilities.

Results

Germacrone exhibits significant potential in the management of chronic diseases, with demonstrated effects on various cellular pathways. The review highlights its impact on NF-κB, PI3K/AKT/mTOR, p53, JAK/STAT, caspase, apoptosis, and autophagy induction, showcasing its versatility in targeting multiple pathways associated with chronic conditions. Germacrone has emerged as a promising candidate for the treatment of diverse chronic diseases. The understanding of its multi-targeting capabilities, coupled with its natural origin, positions it as a valuable scaffold for developing therapeutics.

Conclusion

The exploration of germacrone as a structural framework for multi-targeting drugs offers a potential avenue to enhance efficacy while minimizing potential side effects. Further research and clinical trials are warranted to validate the therapeutic potential of germacrone in diverse medical contexts.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/acamc/10.2174/0118715206312324240805075050
2024-12-01
2025-06-21

  • From This Site

    /content/journals/acamc/10.2174/0118715206312324240805075050
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GuptaS.C. PatchvaS. KohW. AggarwalB.B. Discovery of curcumin, a component of golden spice, and its miraculous biological activities.Clin. Exp. Pharmacol. Physiol.201239328329910.1111/j.1440‑1681.2011.05648.x 22118895
     [Google Scholar]
  2. BordoloiD. RoyN.K. MonishaJ. PadmavathiG. KunnumakkaraA.B. Multi-targeted agents in cancer cell chemosensitization: what we learnt from curcumin thus far.Recent Patents Anticancer Drug Discov.2016111679710.2174/1574892810666151020101706 26537958
     [Google Scholar]
  3. GuptaS.C. PrasadS. KimJ.H. PatchvaS. WebbL.J. PriyadarsiniI.K. AggarwalB.B. Multitargeting by curcumin as revealed by molecular interaction studies.Nat. Prod. Rep.201128121937195510.1039/c1np00051a 21979811
     [Google Scholar]
  4. KunnumakkaraA.B. AnandP. AggarwalB.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.Cancer Lett.2008269219922510.1016/j.canlet.2008.03.009 18479807
     [Google Scholar]
  5. MakhobaX.H. ViegasC.Jr MosaR.A. ViegasF.P.D. PooeO.J. Potential impact of the multi-target drug approach in the treatment of some complex diseases.Drug Des. Devel. Ther.2020143235324910.2147/DDDT.S257494 32884235
     [Google Scholar]
  6. StoletovK. BeattyP.H. LewisJ.D. Novel therapeutic targets for cancer metastasis.Expert Rev. Anticancer Ther.20202029710910.1080/14737140.2020.1718496 31997674
     [Google Scholar]
  7. ŠormF. Advances in terpene chemistry.Pure Appl. Chem.197021226328410.1351/pac197021020263
     [Google Scholar]
  8. TakedaK. HoribeI. MinatoH. Cope rearrangement of some germacrane-type furan sesquiterpenes. Part IV. Preparation of some cyclodeca-cis,trans-diene derivatives and their Cope rearrangements.J. Chem. Soc., Perkin Trans. 11973I2212222010.1039/p19730002212
     [Google Scholar]
  9. EndoJ. NagasawaM. Studies on the essential oil of Asarum caulescens.Yakugaku Zasshi197494121574157910.1248/yakushi1947.94.12_1574 4477187
     [Google Scholar]
  10. HikinoH. KonnoC. NagashimaT. KohamaT. TakemotoT. Stereoselective epoxidation of germacrone by Cunninghamella blakesleeana.Tetrahedron Lett.197112433734010.1016/S0040‑4039(01)96435‑4
     [Google Scholar]
  11. TakedaK. HoribeI. MinatoH. Preparation of some cis-1,trans-5-germacratriene derivatives.J. Chem. Soc. D197122878810.1039/c29710000087
     [Google Scholar]
  12. SchefferJ.R. BoireB.A. Solution photochemistry. II. The photolysis of isogermacrone.Tetrahedron Lett.196910454005400810.1016/S0040‑4039(01)88599‑3
     [Google Scholar]
  13. TakahashiT. KitamuraK. NemotoH. TsujiJ. MiuraI. A first total synthesis of Germacrone by intramolecular alkylation of protected cyanohydrin.Tetrahedron Lett.198324333489349210.1016/S0040‑4039(00)86020‑7
     [Google Scholar]
  14. SakuiN. KuroyanagiM. IshitobiY. SatoM. UenoA. Biotransformation of sesquiterpenes by cultured cells of Curcuma zedoaria.Phytochemistry199231114314710.1016/0031‑9422(91)83023‑E
     [Google Scholar]
  15. AsakawaY. TakahashiH. ToyotaM. Biotransformation of germacrane-type sesquiterpenoids by Aspergillus niger.Phytochemistry199130123993399710.1016/0031‑9422(91)83451‑P
     [Google Scholar]
  16. SakamotoS. TsuchiyaN. KuroyanagiM. UenoA. Biotransformation of germacrone by suspension cultured cells.Phytochemistry19943551215121910.1016/S0031‑9422(00)94823‑4
     [Google Scholar]
  17. LouG. HuangY. WangY. ChenS. LiuC. LiY. FengJ. Germacrone, a novel and safe anticancer agent from genus Curcuma: A review of its mechanism.Anticancer. Agents Med. Chem.202323131490149810.2174/1871520623666230420094628 37139672
     [Google Scholar]
  18. HashemS. NisarS. SageenaG. MachaM.A. YadavS.K. KrishnankuttyR. UddinS. HarisM. BhatA.A. Therapeutic effects of curcumol in several diseases; an overview.Nutr. Cancer202173218119510.1080/01635581.2020.1749676 32285707
     [Google Scholar]
  19. OhS. HanA.R. ParkH.R. JangE.J. KimH.K. JeongM.G. SongH. ParkG.H. SeoE.K. HwangE.S. Suppression of Inflammatory cytokine production by ar-Turmerone isolated from Curcuma phaeocaulis.Chem. Biodivers.20141171034104110.1002/cbdv.201300397 25044589
     [Google Scholar]
  20. FengJ. BaiX. CuiT. ZhouH. ChenY. XieJ. ShiQ. WangH. ZhangG. in vitro antiviral activity of germacrone against porcine reproductive and respiratory syndrome virus.Curr. Microbiol.201673331732310.1007/s00284‑016‑1042‑8 27178541
     [Google Scholar]
  21. HeW. ZhaiX. SuJ. YeR. ZhengY. SuS. Antiviral activity of germacrone against pseudorabies virus in vitro.Pathogens20198425810.3390/pathogens8040258 31766701
     [Google Scholar]
  22. BurapanS. KimM. PaisooksantivatanaY. EserB.E. HanJ. Thai Curcuma species: Antioxidant and bioactive compounds.Foods202099121910.3390/foods9091219 32887356
     [Google Scholar]
  23. SuphromN. PumthongG. KhoranaN. WaranuchN. LimpeanchobN. IngkaninanK. Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb.Fitoterapia201283586487110.1016/j.fitote.2012.03.017 22465508
     [Google Scholar]
  24. ChenY. DongY. JiaoY. HouL. ShiY. GuT. ZhouP. ShiZ. XuL. WangC. In vitro antiviral activity of germacrone against porcine parvovirus.Arch. Virol.201516061415142010.1007/s00705‑015‑2393‑3 25813663
     [Google Scholar]
  25. WuT. YinF. KongH. PengJ. Germacrone attenuates cerebral ischemia/reperfusion injury in rats via antioxidative and antiapoptotic mechanisms.J. Cell. Biochem.201912011189011890910.1002/jcb.29210 31318092
     [Google Scholar]
  26. ZhangR. TianA. ShiX. YuH. ChenL. Downregulation of IL-17 and IFN-γ in the optic nerve by β-elemene in experimental autoimmune encephalomyelitis.Int. Immunopharmacol.201010773874310.1016/j.intimp.2010.04.003 20399285
     [Google Scholar]
  27. KubrakM.N. NguyenT.N.T. NguyenM.P. Study of the composition of essential oil of two species of Dracocephalum, Labiatae. Biologicheskie i Khimicheskie Nauki, 197819782428
     [Google Scholar]
  28. b ZhangG. LingJ. CuiZ. Supercritical CO2 extraction of essential oil from Dracocephalum tanguticum Maxim and analysis by GC-MS. J. Liq. Chromatogr. Relat. Technol., 200730228729210.1080/10826070601064607
     [Google Scholar]
  29. c AhmadiL. MirzaM. . Volatile constituents of Dracocephalum aucheri Boiss. J. Essent. Oil Res., 2001134202203
     [Google Scholar]
  30. d Barrero,A.F. HerradorM.M. ArteagaP. Germacrone: Occurrence, synthesis, chemical transformations and biological properties. Nat. Prod. Commun., 200730228729210.1080/10826070601064607
     [Google Scholar]
  31. a KuroyanagiM. UenoA. UjiieK. SatoS. Structures of sesquiterpenes from Curcuma aromatica Salisb.Chem. Pharm. Bull. 1987351535910.1248/cpb.35.53
     [Google Scholar]
  32. b ChoudhuryS.N. GhoshA.C. SaikiaM. ChoudhuryM. LeclercqP.A. Volatile constituents of the aerial and underground parts of Curcuma aromatica Salisb. from India.J. Essent. Oil Res.19968663363810.1080/10412905.1996.9701031
     [Google Scholar]
  33. a DossR.P. HathewayW.H. HrutfiordB.F. Composition of essential oils of some lipidote Rhododendrons.Phytochemistry19862571637164010.1016/S0031‑9422(00)81225‑X
     [Google Scholar]
  34. b DossR.P. LuthiR. HrutfiordB.F. Germacrone, a sesquiterpene repellent to obscure root weevil from Rhododendron edgeworthii.Phytochemistry198019112379238010.1016/S0031‑9422(00)91031‑8
     [Google Scholar]
  35. c LuY. WangY. BaiY. Study on the chemical composition of the essential oil of Rhododendron anthopogonoides Maxim.Huaxue Xuebao198038140148
     [Google Scholar]
  36. a BordoloiA.K. SperkovaJ. LeclercqP.A. Essential oils of Zingiber cassumunar Roxb. from northeast India.J. Essent. Oil Res.199911441445
     [Google Scholar]
  37. b SrivastavaA.K. SrivastavaS.K. ShahN.C. Essential oil of Zingiber zarumbet (L.) Sm. from India.J. Essent. Oil Res.20001259559710.1016/S0031‑9422(00)91031‑8
     [Google Scholar]
  38. HossainC.F. Al-AminM. SayemA.S.M. SirageeI.H. TunanA.M. HassanF. KabirM.M. SultanaG.N.N. Antinociceptive principle from Curcuma aeruginosa.BMC Complement. Altern. Med.201515119110.1186/s12906‑015‑0720‑6 26092132
     [Google Scholar]
  39. CardosoF. HarbeckN. FallowfieldL. KyriakidesS. SenkusE. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann. Oncol.201223Suppl. 7vii11vii1910.1093/annonc/mds232 22997442
     [Google Scholar]
  40. WilkinsonL. GathaniT. Understanding breast cancer as a global health concern.Br. J. Radiol.20229511302021103310.1259/bjr.20211033 34905391
     [Google Scholar]
  41. SongA. YinY. A brief summary of recent research and application of Ezhu essential oil in tumor therapy.J. Shandong University TCM.200832172174
     [Google Scholar]
  42. XieX.H. ZhaoH. HuY.Y. GuX.D. Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells.Exp. Ther. Med.2014851611161510.3892/etm.2014.1932 25289068
     [Google Scholar]
  43. ZhongZ. ChenX. TanW. XuZ. ZhouK. WuT. CuiL. WangY. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis.Eur. J. Pharmacol.20116671-3505510.1016/j.ejphar.2011.03.041 21497161
     [Google Scholar]
  44. KhanM.Z.I. UzairM. NazliA. ChenJ.Z. An overview on Estrogen receptors signaling and its ligands in breast cancer.Eur. J. Med. Chem.202224111465810.1016/j.ejmech.2022.114658 35964426
     [Google Scholar]
  45. ShastryM. HamiltonE. Novel estrogen receptor-targeted agents for breast cancer.Curr. Treat. Options Oncol.202324782184410.1007/s11864‑023‑01079‑y 37129836
     [Google Scholar]
  46. DasA. LavanyaK.J. Nandini; Kaur, K.; Jaitak, V. Effectiveness of selective estrogen receptor modulators in breast cancer therapy: An update.Curr. Med. Chem.202330293287331410.2174/0929867329666221006110528 36201273
     [Google Scholar]
  47. LimM.S. ChoungS.Y. JeongK.W. Germacrone inhibits estrogen receptor α‐mediated transcription in MCF‐7 breast cancer cells.Phytother. Res.201630122036204310.1002/ptr.5711 27573551
     [Google Scholar]
  48. SungH. FerlayJ. SiegelR.L. LaversanneM. SoerjomataramI. JemalA. BrayF. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.21660 33538338
     [Google Scholar]
  49. Abu RousF. SinghiE.K. SridharA. FaisalM.S. DesaiA. Lung cancer treatment advances in 2022.Cancer Invest.2023411122410.1080/07357907.2022.2119479 36036470
     [Google Scholar]
  50. AllemaniC. MatsudaT. Di CarloV. HarewoodR. MatzM. NikšićM. BonaventureA. ValkovM. JohnsonC.J. EstèveJ. OgunbiyiO.J. Azevedo e SilvaG. ChenW.Q. EserS. EngholmG. StillerC.A. MonnereauA. WoodsR.R. VisserO. LimG.H. AitkenJ. WeirH.K. ColemanM.P. BouzbidS. Hamdi-ChérifM. ZaidiZ. MeguenniK. RegagbaD. BayoS. Cheick BougadariT. ManrajS.S. BendahhouK. FabowaleA. BradshawD. SomdyalaN.I.M. KumcherI. MorenoF. CalabranoG.H. EspinolaS.B. Carballo QuinteroB. FitaR. DiumenjoM.C. LaspadaW.D. IbañezS.G. LimaC.A. De SouzaP.C.F. Del PinoK. LaporteC. CuradoM.P. de OliveiraJ.C. VenezianoC.L.A. VenezianoD.B. LatorreM.R.D.O. TanakaL.F. RebeloM.S. SantosM.O. GalazJ.C. Aparicio AravenaM. Sanhueza MonsalveJ. HerrmannD.A. VargasS. HerreraV.M. UribeC.J. BravoL.E. GarciaL.S. Arias-OrtizN.E. MorantesD. JuradoD.M. Yépez ChamorroM.C. DelgadoS. RamirezM. Galán AlvarezY.H. TorresP. Martínez-ReyesF. JaramilloL. QuintoR. CastilloJ. MendozaM. CuevaP. YépezJ.G. BhakkanB. DeloumeauxJ. JoachimC. MacniJ. CarrilloR. Shalkow KlincovsteinJ. Rivera GomezR. PoquiomaE. Tortolero-LunaG. ZavalaD. AlonsoR. BarriosE. EckstrandA. NikiforukC. NoonanG. TurnerD. KumarE. ZhangB. McCrateF.R. RyanS. MacIntyreM. Saint-JacquesN. NishriD.E. McClureC.A. VriendsK.A. KozieS. Stuart-PankoH. FreemanT. GeorgeJ.T. BrockhouseJ.T. O’BrienD.K. HoltA. AlmonL. KwongS. MorrisC. RycroftR. MuellerL. PhillipsC.E. BrownH. CromartieB. SchwartzA.G. VigneauF. LevinG.M. WohlerB. BayaklyR. WardK.C. GomezS.L. McKinleyM. CressR. GreenM.D. MiyagiK. RuppertL.P. LynchC.F. HuangB. TuckerT.C. DeapenD. LiuL. HsiehM.C. WuX.C. SchwennM. GershmanS.T. KnowltonR.C. AlversonG. CopelandG.E. BushhouseS. RogersD.B. Jackson-ThompsonJ. LemonsD. ZimmermanH.J. HoodM. Roberts-JohnsonJ. ReesJ.R. RiddleB. PawlishK.S. StroupA. KeyC. WigginsC. KahnA.R. SchymuraM.J. RadhakrishnanS. RaoC. GiljahnL.K. SlocumbR.M. EspinozaR.E. KhanF. AirdK.G. BeranT. RubertoneJ.J. SlackS.J. GarciaL. RousseauD.L. JanesT.A. SchwartzS.M. BolickS.W. HurleyD.M. WhitesideM.A. Miller-GianturcoP. WilliamsM.A. HergetK. SweeneyC. JohnsonA.T. Keitheri CheteriM.B. Migliore SantiagoP. BlankenshipS.E. FarleyS. BorchersR. MalickiR. EspinozaJ.R. GrandpreJ. WilsonR. EdwardsB.K. MariottoA. LeiY. WangN. ChenJ.S. ZhouY. HeY.T. SongG.H. GuX.P. MeiD. MuH.J. GeH.M. WuT.H. LiY.Y. ZhaoD.L. JinF. ZhangJ.H. ZhuF.D. JunhuaQ. YangY.L. JiangC.X. BiaoW. WangJ. LiQ.L. YiH. ZhouX. DongJ. LiW. FuF.X. LiuS.Z. ChenJ.G. ZhuJ. LiY.H. LuY.Q. FanM. HuangS.Q. GuoG.P. ZhaolaiH. WeiK. ZengH. DemetriouA.V. MangW.K. NganK.C. KatakiA.C. KrishnatreyaM. JayalekshmiP.A. SebastianP. NandakumarA. MalekzadehR. RoshandelG. Keinan-BokerL. SilvermanB.G. ItoH. NakagawaH. SatoM. ToboriF. NakataI. TeramotoN. HattoriM. KaizakiY. MokiF. SugiyamaH. UtadaM. NishimuraM. YoshidaK. KurosawaK. NemotoY. NarimatsuH. SakaguchiM. KanemuraS. NaitoM. NarisawaR. MiyashiroI. NakataK. SatoS. YoshiiM. OkiI. FukushimaN. ShibataA. IwasaK. OnoC. NimriO. JungK.W. WonY.J. AlawadhiE. ElbasmiA. Ab MananA. AdamF. SanjaajmatsE. TudevU. OchirC. Al KhaterA.M. El MistiriM.M. TeoY.Y. ChiangC.J. LeeW.C. BuasomR. SangrajrangS. Kamsa-ardS. WiangnonS. DaoprasertK. PongnikornD. LeklobA. SangkitipaiboonS. GeaterS.L. SriplungH. CeylanO. KögI. DiricanO. KöseT. GurbuzT. KaraşahinF.E. TurhanD. AktaşU. HalatY. YakutC.I. AltinisikM. CavusogluY. TürkköylüA. ÜçüncüN. HacklM. ZborovskayaA.A. AleinikovaO.V. HenauK. Van EyckenL. ValerianovaZ. YordanovaM.R. ŠekerijaM. DušekL. ZvolskýM. StormH. InnosK. MägiM. MalilaN. SeppäK. JéguJ. VeltenM. CornetE. TroussardX. BouvierA.M. GuizardA.V. BouvierV. LaunoyG. ArveuxP. MaynadiéM. MounierM. WoronoffA.S. DaoulasM. RobaszkiewiczM. ClavelJ. GoujonS. LacourB. BaldiI. PouchieuC. AmadeoB. CoureauG. OrazioS. PreuxP.M. RharbaouiF. MarrerE. TrétarreB. ColonnaM. DelafosseP. LigierK. PlouvierS. Cowppli-BonyA. MoliniéF. BaraS. GanryO. Lapôtre-LedouxB. GrosclaudeP. BossardN. UhryZ. BrayF. PiñerosM. StabenowR. Wilsdorf-KöhlerH. EberleA. LuttmannS. LöhdenI. NenneckeA.L. KieschkeJ. SirriE. EmrichK. ZeissigS.R. HolleczekB. EisemannN. KatalinicA. AsquezR.A. KumarV. PetridouE. ÓlafsdóttirE.J. TryggvadóttirL. Clough-GorrK. WalshP.M. SundsethH. MazzoleniG. VittadelloF. CovielloE. CuccaroF. GalassoR. SampietroG. GiacominA. MagoniM. ArdizzoneA. D’ArgenzioA. CastaingM. GrossoG. LavecchiaA.M. Sutera SardoA. GolaG. GattiL. RicciP. FerrettiS. SerrainoD. ZucchettoA. CelesiaM.V. FilibertiR.A. PannozzoF. MelcarneA. QuartaF. RussoA.G. CarrozziG. CirilliC. Cavalieri d’OroL. RognoniM. FuscoM. VitaleM.F. UsalaM. CusimanoR. MazzuccoW. MichiaraM. SgargiP. BoschettiL. BorcianiE. SeghiniP. MauleM.M. MerlettiF. TuminoR. MancusoP. VicentiniM. CassettiT. SassatelliR. FalciniF. GiorgettiS. CaiazzoA.L. CavalloR. CesaraccioR. PirinoD.R. ContrinoM.L. TisanoF. FanettiA.C. MasperoS. CaroneS. MincuzziA. CandelaG. ScuderiT. GentiliniM.A. PifferS. RossoS. BarchielliA. CaldarellaA. BianconiF. StracciF. ContieroP. TagliabueG. RuggeM. ZorziM. BeggiatoS. BrustolinA. BerrinoF. GattaG. SantM. BuzzoniC. MangoneL. CapocacciaR. De AngelisR. ZanettiR. MaurinaA. PildavaS. LipunovaN. VincerževskienéI. AgiusD. CallejaN. SieslingS. LarønningenS. MøllerB. Dyzmann-SrokaA. TrojanowskiM. GóźdźS. MężykR. MierzwaT. MolongL. RachtanJ. SzewczykS. BłaszczykJ. KępskaK. KościańskaB. TarocińskaK. ZwierkoM. DrosikK. MaksimowiczK.M. Purwin-PorowskaE. RecaE. Wójcik-TomaszewskaJ. TukiendorfA. Grądalska-LampartM. RadziszewskaA.U. GosA. TalerczykM. WyborskaM. DidkowskaJ.A. WojciechowskaU. Bielska-LasotaM. Forjaz de LacerdaG. RegoR.A. BastosJ. SilvaM.A. AntunesL. Laranja PontesJ. Mayer-da-SilvaA. MirandaA. BlagaL.M. CozaD. GusenkovaL. LazarevichO. PrudnikovaO. VjushkovD.M. EgorovaA.G. OrlovA.E. KudyakovL.A. PikalovaL.V. AdamcikJ. Safaei DibaC. Primic-ŽakeljM. ZadnikV. LarrañagaN. Lopez de MunainA. HerreraA.A. RedondasR. Marcos-GrageraR. Vilardell GilM.L. MolinaE. Sánchez PerezM.J. Franch SuredaP. Ramos MontserratM. ChirlaqueM.D. NavarroC. ArdanazE.E. GuevaraM.M. Fernández-DelgadoR. Peris-BonetR. CarullaM. GalceranJ. AlberichC. Vicente-RanedaM. KhanS. PetterssonD. DickmanP. AvelinaI. StaehelinK. CameyB. BouchardyC. SchaffarR. FrickH. HerrmannC. BulliardJ.L. Maspoli-ConconiM. KuehniC.E. RedmondS.M. BordoniA. OrtelliL. ChioleroA. KonzelmannI. MatthesK.L. RohrmannS. BroggioJ. RashbassJ. FitzpatrickD. GavinA. ClarkD.I. DeasA.J. HuwsD.W. WhiteC. MontelL. RachetB. TurculetA.D. StephensR. ChalkerE. PhungH. WaltonR. YouH. GuthridgeS. JohnsonF. GordonP. D’OniseK. PriestK. StokesB.C. VennA. FarrugiaH. ThursfieldV. DowlingJ. CurrowD. HendrixJ. LewisC. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.Lancet2018391101251023107510.1016/S0140‑6736(17)33326‑3 29395269
     [Google Scholar]
  51. NanY. SuH. ZhouB. LiuS. The function of natural compounds in important anticancer mechanisms. Front. Oncol., 202312, 104988812, 1049888.10.3389/fonc.2022.104988836686745
     [Google Scholar]
  52. CollinsL.G. HainesC. PerkelR. EnckR.E. Lung cancer: diagnosis and management.Am. Fam. Physician20077515663
     [Google Scholar]
  53. ZhaoY. CaiJ. ShiK. LiH. DuJ. HuD. LiuZ. WangW. Germacrone induces lung cancer cell apoptosis and cell cycle arrest via the Akt/MDM2/p53 signaling pathway.Mol. Med. Rep.202123645210.3892/mmr.2021.12091 33880579
     [Google Scholar]
  54. AnwanwanD. SinghS.K. SinghS. SaikamV. SinghR. Challenges in liver cancer and possible treatment approaches.Biochim. Biophys. Acta Rev. Cancer20201873118831410.1016/j.bbcan.2019.188314 31682895
     [Google Scholar]
  55. RumgayH. FerlayJ. de MartelC. GeorgesD. IbrahimA.S. ZhengR. WeiW. LemmensV.E.P.P. SoerjomataramI. Global, regional and national burden of primary liver cancer by subtype.Eur. J. Cancer202216110811810.1016/j.ejca.2021.11.023 34942552
     [Google Scholar]
  56. LiuY. WangW. FangB. MaF. ZhengQ. DengP. ZhaoS. ChenM. YangG. HeG. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.Eur. J. Pharmacol.20136981-39510210.1016/j.ejphar.2012.10.013 23117090
     [Google Scholar]
  57. LiZ. WangZ. DongF. ShiW. DaiW. ZhaoJ. LiQ. FangZ. RenL. LiuT. WeiZ. MouW. LinL. YangY. XiaoX. MaL. BaiZ. Germacrone attenuates hepatic stellate cells activation and liver fibrosis via regulating multiple signaling pathways.Front. Pharmacol.20211274556110.3389/fphar.2021.745561 34675811
     [Google Scholar]
  58. SunX. ZhongX. MaW. FengW. HuangQ. MaM. LvM. HuR. HanZ. LiJ. ZhouX. Germacrone induces caspase 3/GSDME activation and enhances ROS production, causing HepG2 pyroptosis.Exp. Ther. Med.202224145610.3892/etm.2022.11383 35747157
     [Google Scholar]
  59. TuliH.S. KaurJ. VashishthK. SakK. SharmaU. ChoudharyR. BehlT. SinghT. SharmaS. SainiA.K. DhamaK. VarolM. SethiG. Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis.Arch. Toxicol.202397110312010.1007/s00204‑022‑03421‑z 36443493
     [Google Scholar]
  60. WuJ. FengY. HanC. HuangW. ShenZ. YangM. ChenW. YeL. Germacrone derivatives: synthesis, biological activity, molecular docking studies and molecular dynamics simulations.Oncotarget201789151491515810.18632/oncotarget.14832 28148897
     [Google Scholar]
  61. YeL. WuJ. ChenW. FengY. ShenZ. Novel anti-cancer agents based on germacrone: Design, synthesis, biological activity, docking studies and MD simulations.RSC Advances2017773760376710.1039/C6RA26944C
     [Google Scholar]
  62. ChenC. XieL. RenT. HuangY. XuJ. GuoW. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs.Cancer Lett.202150011010.1016/j.canlet.2020.12.024 33359211
     [Google Scholar]
  63. CersosimoF. LonardiS. BernardiniG. TelferB. MandelliG.E. SantucciA. VermiW. GiurisatoE. Tumor-associated macrophages in osteosarcoma: From mechanisms to therapy.Int. J. Mol. Sci.20202115520710.3390/ijms21155207 32717819
     [Google Scholar]
  64. LiE. GaoY. MouL. ZhangZ. Anticancer activity of Germacrone terpenoid in human osteosarcoma cells is mediated via autophagy induction, cell cycle disruption, downregulating the cell cycle regulatory protein expressions and cell migration inhibition.Acta Biochim. Pol.202269230530810.18388/abp.2020_5712 35468267
     [Google Scholar]
  65. HaradaK. RogersJ.E. IwatsukiM. YamashitaK. BabaH. AjaniJ.A. Recent advances in treating oesophageal cancer.F1000 Res.202019
     [Google Scholar]
  66. BolgerJ.C. DonohoeC.L. LoweryM. ReynoldsJ.V. Advances in the curative management of oesophageal cancer.Br. J. Cancer2022126570671710.1038/s41416‑021‑01485‑9 34675397
     [Google Scholar]
  67. HuangH. Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances.Sensors (Basel)20181810324910.3390/s18103249 30262739
     [Google Scholar]
  68. ZhangR. HaoJ. GuoK. LiuW. YaoF. WuQ. LiuC. WangQ. YangX. Germacrone inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cells.BioMed Res. Int.2020202011310.1155/2020/7643248 32071920
     [Google Scholar]
  69. NagaiH. KimY.H. Cancer prevention from the perspective of global cancer burden patterns.J. Thorac. Dis.20179344845110.21037/jtd.2017.02.75 28449441
     [Google Scholar]
  70. SmythE.C. NilssonM. GrabschH.I. van GriekenN.C.T. LordickF. Gastric cancer.Lancet20203961025163564810.1016/S0140‑6736(20)31288‑5 32861308
     [Google Scholar]
  71. McIlwainD.R. BergerT. MakT.W. Caspase functions in cell death and disease.Cold Spring Harb. Perspect. Biol.201354a00865610.1101/cshperspect.a008656 23545416
     [Google Scholar]
  72. WuL. WangL. TianX. ZhangJ. FengH. Germacrone exerts anti-cancer effects on gastric cancer through induction of cell cycle arrest and promotion of apoptosis.BMC Complementary Medicine and Therapies20202012110.1186/s12906‑019‑2810‑3 32020876
     [Google Scholar]
  73. FangX. TanT. GaoB. ZhaoY. LiuT. XiaQ. Germacrone regulates hbxip-mediated cell cycle, apoptosis and promotes the formation of autophagosomes to inhibit the proliferation of gastric cancer cells.Front. Oncol.202010537322
     [Google Scholar]
  74. SchattenH. Brief overview of prostate cancer statistics, grading, Diagnosis and treatment strategies.Adv. Exp. Med. Biol.2018109511410.1007/978‑3‑319‑95693‑0_1 30229546
     [Google Scholar]
  75. PortaC. PaglinoC. MoscaA. Targeting PI3K/Akt/mTOR signaling in cancer.Front. Oncol.201446410.3389/fonc.2014.00064 24782981
     [Google Scholar]
  76. LoRussoP.M. Inhibition of the PI3K/AKT/mTOR pathway in solid tumors.J. Clin. Oncol.201634313803381510.1200/JCO.2014.59.0018 27621407
     [Google Scholar]
  77. YangJ. NieJ. MaX. WeiY. PengY. WeiX. Targeting PI3K in cancer: Mechanisms and advances in clinical trials.Mol. Cancer20191812610.1186/s12943‑019‑0954‑x 30782187
     [Google Scholar]
  78. WadoskyK.M. KoochekpourS. Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer.Oncotarget2016739644476447010.18632/oncotarget.10901 27487144
     [Google Scholar]
  79. YuZ. XuJ. ShaoM. ZouJ. Germacrone induces apoptosis as well as protective autophagy in human prostate cancer cells.Cancer Manag. Res.2020124009401610.2147/CMAR.S250522 32547235
     [Google Scholar]
  80. Borrescio-HigaF. ValdésN. The psychosocial burden of families with childhood blood cancer.Int. J. Environ. Res. Public Health202219159910.3390/ijerph19010599 35010854
     [Google Scholar]
  81. LiW. WangF. GuoR. BianZ. SongY. Targeting macrophages in hematological malignancies: Recent advances and future directions.J. Hematol. Oncol.202215111010.1186/s13045‑022‑01328‑x 35978372
     [Google Scholar]
  82. BraconiL. TeodoriE. RigantiC. CoronnelloM. NocentiniA. BartolucciG. PallecchiM. ContinoM. ManettiD. RomanelliM.N. SupuranC.T. DeiS. New dual P-glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as multidrug resistance (MDR) reversers in cancer cells.J. Med. Chem.20226521146551467210.1021/acs.jmedchem.2c01175 36269278
     [Google Scholar]
  83. AzzaritiA. PorcelliL. Elisa QuatraleA. SilvestrisN. ParadisoA. The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy.Curr. Drug Metab.201112871372110.2174/138920011798357042 21434858
     [Google Scholar]
  84. PanJ. MiaoD. ChenL. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.Chem. Biol. Interact.2018288323710.1016/j.cbi.2018.04.012 29655913
     [Google Scholar]
  85. GisinaA. KholodenkoI. KimY. AbakumovM. LupatovA. YaryginK. Glioma stem cells: Novel data obtained by single-cell sequencing.Int. J. Mol. Sci.202223221422410.3390/ijms232214224 36430704
     [Google Scholar]
  86. LiuB.O. GaoY.U.E.Q.I.U. WangX.M. WangY.C. FuL.I.Q.I. Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest.Mol. Med. Rep.20141021046105010.3892/mmr.2014.2290 24889088
     [Google Scholar]
  87. KamatP.K. RaiS. NathC. Okadaic acid induced neurotoxicity: An emerging tool to study Alzheimer’s disease pathology.Neurotoxicology20133716317210.1016/j.neuro.2013.05.002 23688530
     [Google Scholar]
  88. ÇakırM. YükselF. Mustafa ÖzkutM. DurhanM. KaymakE. TekinS. ÇiğremişY. Neuroprotective effect of transient receptor potential Vanilloid 1 agonist capsaicin in Alzheimer’s disease model induced with okadaic acid.Int. Immunopharmacol.202311810992510.1016/j.intimp.2023.109925 37011502
     [Google Scholar]
  89. LinM. LiP. LiuW. NiuT. HuangL. Germacrone alleviates okadaic acid-induced neurotoxicity in PC12 cells via M1 muscarinic receptor-mediated Galphaq (Gq)/phospholipase C beta (PLCβ)/protein kinase C (PKC) signaling.Bioengineered20221334898491010.1080/21655979.2022.2036918 35156515
     [Google Scholar]
  90. SahaS. ButtariB. PanieriE. ProfumoE. SasoL. An overview of Nrf2 signaling pathway and its role in inflammation.Molecules20202522547410.3390/molecules25225474 33238435
     [Google Scholar]
  91. El-ShitanyN.A. EidB.G. Icariin modulates carrageenan-induced acute inflammation through HO-1/Nrf2 and NF-kB signaling pathways.Biomed. Pharmacother.201912010956710.1016/j.biopha.2019.109567 31670031
     [Google Scholar]
  92. ZhuangS. LiuB. GuoS. XueY. WuL. LiuS. ZhangC. NiX. Germacrone alleviates neurological deficits following traumatic brain injury by modulating neuroinflammation and oxidative stress.BMC Comple. Med. Therap.2021211610.1186/s12906‑020‑03175‑0 33402180
     [Google Scholar]
  93. Malik PeirisJ.S. PoonL.L.M. GuanY. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans.J. Clin. Virol.200945316917310.1016/j.jcv.2009.06.006 19540800
     [Google Scholar]
  94. MolinariN.A.M. Ortega-SanchezI.R. MessonnierM.L. ThompsonW.W. WortleyP.M. WeintraubE. BridgesC.B. The annual impact of seasonal influenza in the US: Measuring disease burden and costs.Vaccine200725275086509610.1016/j.vaccine.2007.03.046 17544181
     [Google Scholar]
  95. RothbergM.B. HaesslerS.D. BrownR.B. Complications of viral influenza.Am. J. Med.2008121425826410.1016/j.amjmed.2007.10.040 18374680
     [Google Scholar]
  96. LiaoQ. QianZ. LiuR. AnL. ChenX. Germacrone inhibits early stages of influenza virus infection.Antiviral Res.2013100357858810.1016/j.antiviral.2013.09.021 24095670
     [Google Scholar]
  97. BergerA. Science commentary: Th1 and Th2 responses: What are they?BMJ2000321725842410.1136/bmj.321.7258.424 10938051
     [Google Scholar]
  98. LiuT. ZhangL. JooD. SunS.C. NF-κB signaling in inflammation.Signal Transduct. Target. Ther.2017211702310.1038/sigtrans.2017.23 29158945
     [Google Scholar]
  99. ShiS. ChenY. LuoZ. NieG. DaiY. Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy.Cell Commun. Signal.20232116110.1186/s12964‑023‑01077‑5 36918950
     [Google Scholar]
  100. ChenY. FangZ.M. YiX. WeiX. JiangD.S. The interaction between ferroptosis and inflammatory signaling pathways.Cell Death Dis.202314320510.1038/s41419‑023‑05716‑0 36944609
     [Google Scholar]
  101. WangZ. ZhuoF. ChuP. YangX. ZhaoG. Germacrone alleviates collagen-induced arthritis via regulating Th1/Th2 balance and NF-κB activation.Biochem. Biophys. Res. Commun.2019518356056410.1016/j.bbrc.2019.08.084 31451221
     [Google Scholar]
  102. ChellappanD.K. YapW.S. Bt Ahmad SuhaimiN.A. GuptaG. DuaK. Current therapies and targets for type 2 diabetes mellitus.Panminerva Med.201860311713110.23736/S0031‑0808.18.03455‑9 29696964
     [Google Scholar]
  103. CarlingD. AMPK signalling in health and disease.Curr. Opin. Cell Biol.201745313710.1016/j.ceb.2017.01.005 28232179
     [Google Scholar]
  104. SunY. LiL. WuJ. GongB. LiuH. Germacrone cooperates with dexmedetomidine to alleviate high fat diet induced type 2 diabetes mellitus via upregulating AMPKα1 expression.Exp. Ther. Med.20191853514352410.3892/etm.2019.7990 31602228
     [Google Scholar]
  105. GuoY.R. ChoungS.Y. Germacrone attenuates hyperlipidemia and improves lipid metabolism in high-fat diet-induced obese C57BL/6J Mice.J. Med. Food2017201465510.1089/jmf.2016.3811 28098516
     [Google Scholar]
  106. JiD. WangQ. ZhaoQ. TongH. YuM. WangM. LuT. JiangC. Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy.J. Nanobiotechnology20201818610.1186/s12951‑020‑00645‑y 32513194
     [Google Scholar]
  107. FangZ. YushanjiangF. WangG. ZhengX. JiangX. Germacrone mitigates cardiac remodeling by regulating PI3K/AKTmediated oxidative stress, inflammation, and apoptosis. 2023124110876
     [Google Scholar]
  108. ZhangY. AlexanderP.B. WangX.F. TGF-β family signaling in the control of cell proliferation and survival.Cold Spring Harb. Perspect. Biol.201794a02214510.1101/cshperspect.a022145 27920038
     [Google Scholar]
  109. HuH.H. ChenD.Q. WangY.N. FengY.L. CaoG. VaziriN.D. ZhaoY.Y. New insights into TGF-β/Smad signaling in tissue fibrosis.Chem. Biol. Interact.2018292768310.1016/j.cbi.2018.07.008 30017632
     [Google Scholar]
  110. Vander ArkA. CaoJ. LiX. TGF-β receptors: In and beyond TGF-β signaling.Cell. Signal.20185211212010.1016/j.cellsig.2018.09.002 30184463
     [Google Scholar]
  111. ClarkD.A. CokerR. Molecules in focus transforming growth factor-beta (TGF-β).Int. J. Biochem. Cell Biol.199830329329810.1016/S1357‑2725(97)00128‑3 9611771
     [Google Scholar]
  112. Galisteo PretelA. Pérez Del PulgarH. Guerrero de LeónE. López-PérezJ.L. OlmedaA.S. Gonzalez-ColomaA. F BarreroA. Quílez Del MoralJ.F. Germacrone derivatives as new insecticidal and acaricidal compounds: A structure-activity relationship.Molecules20192416289810.3390/molecules24162898 31404973
     [Google Scholar]
  113. LiX. ChenL. WangH. LiY. WuH. GuoF. Germacrone, isolated from Curcuma wenyujin, inhibits melanin synthesis through the regulation of the MAPK signaling pathway. J. Nat. Med., 2024, 2024 Advance online publication10.1007/s11418‑024‑01818‑x 38809333
     [Google Scholar]
  114. YuanY. ShaoL. Germacrone protects against NF-κB-mediated inflammatory signaling, apoptosis, and retinal ganglion cell survival in a rat glaucoma model. TJEM, 2024. Epub ahead of Print10.1620/tjem.2024.J028
     [Google Scholar]
  115. LinZ. YangY. LiuT. WuZ. ZhangX. YangJ. Germacrone alleviates breast cancer‐associated osteolysis by inhibiting osteoclastogenesis via inhibition of MAPK/NF‐κB signaling pathways.Phytother. Res.20243862860287410.1002/ptr.8195 38558446
     [Google Scholar]
  116. WangY. HeX. XueM. YuH. HeQ. JinJ. Integrated 16S rRNA sequencing and metabolomic analysis reveals the potential protective mechanism of Germacrone on diabetic nephropathy in mice.Acta Biochim. Biophys. Sin. 202456341442610.3724/abbs.2024021 38429975
     [Google Scholar]
  117. WangY. HeX. XueM. SunW. HeQ. JinJ. Germacrone protects renal tubular cells against ferroptotic death and ROS release by re-activating mitophagy in diabetic nephropathy.Free radic. res.20235741342910.1080/10715762.2023.2277143
     [Google Scholar]
/content/journals/acamc/10.2174/0118715206312324240805075050
Loading
Germacrone: A Multi-targeting Sesquiterpene with Promising Anti-cancer and Chronic Disease Applications
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) 24, 1396 (2024); https://doi.org/10.2174/0118715206312324240805075050
/content/journals/acamc/10.2174/0118715206312324240805075050
/content/journals/acamc/10.2174/0118715206312324240805075050
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Anti-cancer activity; chronic diseases; germacrone; multi-targeting therapy; natural compounds; therapeutic applications

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test